News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,734 Results
Type
Article (8017)
Company Profile (140)
Press Release (477576)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166769)
Career Advice (305)
Deals (25742)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238259)
Policy (17927)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33161)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (277)
Approvals (10398)
Artificial intelligence (326)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3721)
Cardiovascular disease (225)
Career advice (246)
Career pathing (1)
CAR-T (177)
CDMO (10)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (47994)
Collaboration (1270)
Commercialization (3)
Compensation (1519)
Complete response letters (34)
COVID-19 (760)
CRISPR (64)
C-suite (791)
Cystic fibrosis (86)
Data (5809)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4202)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73751)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88061)
Executive appointments (712)
FDA (12456)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (938)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (294)
Government (955)
Grass and pollen (2)
Guidances (284)
Healthcare (9381)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (950)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5212)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (521)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (554)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8678)
Medtech (8833)
Mergers & acquisitions (14404)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1852)
NextGen: Class of 2026 (3154)
Non-profit (848)
Obesity (227)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (524)
Patient selection (1)
Peanut (31)
People (41344)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15504)
Phase 2 (21425)
Phase 3 (14451)
Pipeline (7605)
Policy (18)
Postmarket research (1572)
Preclinical (6550)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (583)
Real estate (3024)
Recruiting (6)
Regulatory (14918)
Reports (23)
Research institute (585)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Today (7)
Last 7 days (372)
Last 30 days (1396)
Last 365 days (19013)
2026 (13339)
2025 (19257)
2024 (22997)
2023 (26543)
2022 (34589)
2021 (37169)
2020 (33479)
2019 (23257)
2018 (17468)
2017 (18765)
2016 (17926)
2015 (24264)
2014 (21685)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20335)
Location
Africa (228)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17937)
Australia (2106)
California (12273)
Canada (3217)
China (538)
Colorado (491)
Connecticut (424)
Delaware (211)
Europe (24679)
Florida (1840)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (718)
India (52)
Indiana (320)
Iowa (16)
Japan (415)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1223)
Massachusetts (8054)
Michigan (312)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2686)
New Mexico (12)
New York (2878)
North Carolina (1311)
North Dakota (4)
Northern California (6169)
Ohio (288)
Oklahoma (14)
Oregon (16)
Pennsylvania (2289)
Puerto Rico (20)
Rhode Island (32)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5105)
Tennessee (122)
Texas (1990)
United States (39788)
Utah (367)
Vermont (1)
Virginia (156)
Washington D.C. (38)
Washington State (954)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,734 Results for "acclarent inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions.
April 1, 2024
·
5 min read
Press Releases
Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry
July 3, 2025
·
3 min read
Deals
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company for $275 million in cash at closing, subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones.
December 13, 2023
·
7 min read
Biotech Beach
Acclarent Launches First ENT Navigation Technology Powered by Artificial Intelligence
Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies,* and a leader in developing minimally-invasive Ear, Nose & Throat technologies, announced the U.S. launch of its first-ever AI-powered ENT technology, designed to simplify surgical planning and provide real-time feedback during ENT navigation procedures.
September 30, 2021
·
6 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
Press Releases
PostEra’s Fertility programs acquired by EMD Serono, Inc.
September 9, 2026
·
2 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 48,574
Next
